Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] - N0000175820

Pharmacologic Code	N0000175820
Pharmacologic Name	Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Pharmacologic Uses	hydrolytic lysosomal glucocerebroside-specific enzyme hydrolytic lysozomal glucocerebroside-specific enzyme
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0069-0106	Elelyso	Non-Proprietary Name: Taliglucerase Alfa	Injection, Powder, Lyophilized, For Solution	Intravenous	Pfizer Laboratories Div Pfizer Inc	ACTIVE
	54092-701	Vpriv	Non-Proprietary Name: Velaglucerase Alfa	Injection, Powder, Lyophilized, For Solution	Intravenous	Takeda Pharmaceuticals America, Inc.	ACTIVE
	58468-4663	Cerezyme	Non-Proprietary Name: Imiglucerase	Injection, Powder, Lyophilized, For Solution	Intravenous	Genzyme Corporation	ACTIVE